You are here
Home 🌿 Marijuana Politics 🌿 Montana medical marijuana dispensary owner sentenced to federal prison 🌿Montana medical marijuana dispensary owner sentenced to federal prison
The former owner of Montana Buds, a statewide medical marijuana dispensary network, was sentenced Thursday to 18 months in federal prison after pleading guilty to a drug charge.
Charlton Victor Campbell was sentenced by Chief District Court Judge Dana Christensen in U.S. District Court in Missoula. Following his incarceration, he will be under supervised release for an additional five years.
In March, Campbell pleaded guilty to a federal charge of conspiracy to manufacture and distribute marijuana after signing a plea agreement with federal prosecutors that dismissed three other charges.
Under the agreement, Campbell also forfeited $30,000 in cash and gave up the Montana Buds properties in Bozeman to the federal government.
Federal prosecutors contended in court documents that because Campbell had a prior felony conviction, he was not allowed to be a medical marijuana provider. Montana’s original medical marijuana provider rules only banned people with felony drug convictions from being providers, but that ban was expanded by the Legislature in 2011 to include all felonies.
At Campbell’s change of plea hearing, his attorney Josh Van de Wetering said his client stopped being a provider after the rules change, but continued to work with Montana Buds by leasing it property and conducting marketing and other work for the company.
Michael James Mason and Jesse Walter Campbell — two other medical marijuana providers from the Bozeman area — also were charged in the case. Mason eventually pleaded guilty to money laundering in April under a plea agreement that dismissed his drug charges, and will be sentenced Aug. 11.
Jesse Campbell, Charlton’s brother, had been fighting his prosecution, arguing the U.S. Department of Justice shouldn’t have been allowed to bring a case against him because of a federal funding rider — upheld by a federal appellate court — that says drug enforcement agents can’t use funds to go after medical marijuana providers who are obeying their state medical marijuana program laws.
A pair of hearings were held earlier this year in federal court in Missoula to debate the matter, but in early May, Judge Christensen wrote an order denying Campbell’s motion to dismiss. The judge decided that Campbell had broken state medical marijuana laws, in part, by having more marijuana than he was allowed as a provider, meaning the federal agents and prosecutors would be allowed to investigate and charge him.
A week after Christensen issued his order, Jesse Campbell signed a plea agreement with prosecutors that calls for him to plead guilty to a count of maintaining a drug-involved premises. He has a plea change hearing set for June 20 in Butte.
Under his plea agreement, Jesse Campbell also has agreed to forfeit $55,000 in cash and the home and outbuildings in Bozeman he was using to grow and sell medical marijuana.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.